Cite
HARVARD Citation
Kim, H. et al. (n.d.). Is neoadjuvant chemotherapy always justified in clinical T1 pancreatic ductal adenocarcinoma?. HPB. pp. S233-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, H. et al. (n.d.). Is neoadjuvant chemotherapy always justified in clinical T1 pancreatic ductal adenocarcinoma?. HPB. pp. S233-. [Online].